Partner Sites

Fintech leaders urge unified standards as digital payments stay fragmented; digital payments stay fragmented

Fintech leaders urge unified standards as digital payments stay fragmented; digital payments stay fragmented

Singapore to trial tokenised MAS Bills using central bank digital currency; central bank digital currency

Singapore to trial tokenised MAS Bills using central bank digital currency; central bank digital currency

Tokenisation, cyber threats top agenda at Singapore FinTech Festival Day 2

Tokenisation, cyber threats top agenda at Singapore FinTech Festival Day 2

SBR 1 Lorem Ipsum [8 May]

SBR 1 Lorem Ipsum [8 May]

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Lorem Ipsum Manufacuring

Lorem Ipsum Manufacuring

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Toys ‘R’ Us Asia banks on ‘kidults’ to drive toy sales

Toys ‘R’ Us Asia banks on ‘kidults’ to drive toy sales

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

See you in 2025!

See you in 2025!

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Diversity in Asia-Pacific region’s clinical trials pushed

Diversity in Asia-Pacific region’s clinical trials pushed

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Genting Singapore net profit down 5% to $578.9m in FY2024

Genting Singapore net profit down 5% to $578.9m in FY2024

Zhongxin Fruit and Juice records $4m net profit in HY2025

Zhongxin Fruit and Juice records $4m net profit in HY2025

Over 3 in 10 APAC firms expect office usage to increase

Over 3 in 10 APAC firms expect office usage to increase